US Patent 9334325 Method for treating psoriasis
Patent 9334325 was granted and assigned to Biotest AG on May, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+327 characters)
Article
Patent abstract
The present invention provides a pharmaceutical composition for treating an autoimmune disease comprising a pharmaceutically acceptable carrier and an agent capable of activating CD4+CD25+ regulatory T cells, wherein the composition is to be administered to a subject in a dose of the agent from 0.2 mg to 30 mg.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Infobox
Patent Inventor Names
Andrea Wartenberg-Demand0
Benjamin Daelken0
Christoph Bruecher0
Christoph Uherek0
Daniele Wolf0
Elmar Kraus0
Frank Osterroth0
Juergen Lindner0
Matthias Germer0
Sibylle Kaiser0
Silke Aigner0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09334325 Method for treating psoriasis US Patent 9334325 Method for treating psoriasis
Infobox
Patent Number
09334325
Patent Number
9334325
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09334325 Method for treating psoriasis
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09334325
Date of patent
May 10, 2016
Patent application number
12880837
Date Filed
September 13, 2010
Patent primary examiner
Find more entities like US Patent 9334325 Method for treating psoriasis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.